Digi.Bio is revolutionizing the development of therapies with its AI-driven, lab-on-a-chip platform. Designed for high-content, real-time analysis, the technology enables dynamic monitoring of therapy performance at single-cell resolution. With BSL-2 laboratories at Leiden Bio Science Park and its headquarters in Amsterdam, Digi.Bio provides a digital, single-cell representation of therapy responses, offering unprecedented spatial and temporal insights into treatment behavior.
Looking for a particular Digi.Bio employee's phone or email?
Federico Muffatto is the Founder and CEO of Digi.Bio.
5 people are employed at Digi.Bio.
The NAICS codes for Digi.Bio are [541, 54171, 5417, 541713, 54].
The SIC codes for Digi.Bio are [873, 87].